Zhu X J, Niimi Y, Bystryn J C
Department of Dermatology, New York University School of Medicine, New York.
J Invest Dermatol. 1990 Jun;94(6):817-21. doi: 10.1111/1523-1747.ep12874675.
The antigens in normal human skin defined by antibodies in patients with bullous pemphigoid (BP) were studied by Western immunoblots. Eighteen (90%) of 20 BP sera reacted to a 230-kD antigen. Seven (35%) of the sera reacted to a 160-kD antigen. Two of these reacted only to the 160-kD antigen and five also reacted to the 230-kD antigen. Antibodies to the 160-kD antigen were not present in 25 control sera obtained from normal individuals or patients with other bullous diseases. The 160-kD antigen was present in epidermal extracts of four different specimens of normal human skin but not in dermal extracts or extracts of control cells including melanoma, fibroblasts, lung carcinoma, and colon carcinoma. Monospecific sera with antibodies to either the 230-kD or to the 160-kD antigen reacted solely to their respective target antigens, but not to both, in extracts of epidermis that contained both antigens. The 160-kD antigen broke down to a 140-kD fragment, while the 230-kD antigen was unchanged in the absence of protease inhibitors. Western blot affinity purified antibody to the 160-kD antigen bound only to the basement membrane zone on the epidermal side of 1M NaCl split skin. These results indicate that a 160-kD antigen is a normal component of the basement membrane zone of human skin. The antigen is located on the epidermal side of skin split with 1M NaCl. It is a minor BP antigen, antibodies to which are present in some patients with BP.
采用蛋白质免疫印迹法研究了大疱性类天疱疮(BP)患者血清抗体所识别的正常人皮肤抗原。20份BP血清中有18份(90%)与一种230-kD抗原发生反应。7份血清(35%)与一种160-kD抗原发生反应。其中2份血清仅与160-kD抗原发生反应,5份血清同时也与230-kD抗原发生反应。从正常个体或其他大疱性疾病患者获取的25份对照血清中未发现针对160-kD抗原的抗体。160-kD抗原存在于4份不同正常人皮肤标本的表皮提取物中,但不存在于真皮提取物或包括黑色素瘤、成纤维细胞、肺癌和结肠癌在内的对照细胞提取物中。在同时含有两种抗原的表皮提取物中,针对230-kD或160-kD抗原的单特异性血清仅与其各自的靶抗原发生反应,而非与两者均发生反应。在没有蛋白酶抑制剂的情况下,160-kD抗原分解为140-kD片段,而230-kD抗原未发生变化。蛋白质免疫印迹法亲和纯化的针对160-kD抗原的抗体仅与1M NaCl分离皮肤表皮侧的基底膜带结合。这些结果表明,160-kD抗原是人类皮肤基底膜带的正常组成成分。该抗原位于用1M NaCl分离的皮肤的表皮侧。它是一种次要的BP抗原,部分BP患者体内存在针对该抗原的抗体。